When was Pandorum founded?

Pandorum was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is Pandorum located?

Pandorum is headquartered in Bengaluru, India. It is registered at EGF 4 & 5, Bangalore Bioinnovation Centre, Helix Biotech Park, Electronic City Phas, e 1, Bangalore, Bengaluru, Karnataka, India, 560100.

Who is the current CEO of Pandorum?

Tuhin Bhowmick of Pandorum. They have also founded 1 company.

Which legal entities is Pandorum associated with?

Pandorum is associated with PANDORUM TECHNOLOGIES PRIVATE LIMITED.

How many employees does Pandorum have?

As of Aug 31, 2025, Pandorum has 28 employees, reflecting a 8% year-over-year growth in headcount.

Is Pandorum a funded company?

Pandorum is a funded company, having raised a total of $52.1M across 13 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2012.

How much is Pandorum worth?

The latest valuation of Pandorum is ₹***** as of Mar 30, 2026. This marks a decline of 1% from its peak valuation of ₹824Cr in Apr, 2016. This marks a decline of 1% from its peak valuation of ₹824Cr in Apr, 2016.

When was the latest funding round of Pandorum?

Pandorum's latest funding was a $***** Series B round on Mar 20, 2026, with participation from 1 investor. Its primary sector is Regenerative Medicine. Globally, the Regenerative Medicine sector has seen $106M in funding in 2026 to date.

What is the annual revenue of Pandorum?

Annual revenue of Pandorum is less than ₹10 Cr as on Mar 31, 2025

Where does Pandorum rank among its competitors?

Pandorum ranks 2nd amongst 163 active competitors, of which 52 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Pandorum, which secured $429K in Mar, 2026.

Who are the top competitors of Pandorum?

Pandorum's top competitors include InSphero, Ncardia and Avita Medical. Among them, Pandorum secured the most recent funding round in March, 2026.

Pandorum - 2026 Company Profile, Team, Funding, Competitors & Financials

Pandorum is a series B company based in Bengaluru (India), founded in 2011 by Tuhin Bhowmick and Arun Chandru. It operates as a Developer of regenerative medicine and 3D tissues. Pandorum has raised $52.1M in funding from investors like BTB Venture, Indian Angel Network and PROTONS CORPORATE SERVICES, with a current valuation of ₹*****. The company has 163 active competitors, including 52 funded and 16 that have exited. Its top competitors include companies like InSphero, Ncardia and Avita Medical.

Company Details

Developer of regenerative medicine and 3D tissues. It has developed a working 3D tissue through 3D printing and fabrication techniques. The products include bioengineered cornea which is a hydrogel formulation used for blindness, 3D hepatocyte spheroids for drug discovery and liver therapies, and exosome cell-free therapy for lung regeneration.

Website: pandorum.com
Social
Email ID: *****@pandorumtechnologies.in
Phone Number: +91 **********
Registered Address: EGF 4 & 5, Bangalore Bioinnovation Centre, Helix Biotech Park, Electronic City Phas, e 1, Bangalore, Bengaluru, Karnataka, India, 560100

Key Metrics

Founded Year

2011

Location

Bengaluru, India

Stage

Series B

Total Funding

$52.1M in 13 rounds

Latest Funding Round

Series B, Mar 20, 2026, $*****

Post Money Valuation

₹***** as on Mar 30, 2026

Investors

BTB Venture & 89 more

Ranked

2^nd among 163 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

28 as on Aug 31, 2025

Similar Companies

InSphero & 153 more

View Pandorum's full profile

Pandorum is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PANDORUM TECHNOLOGIES PRIVATE LIMITED CIN: U72200KA2011PTC058650 , India, Active	May 16, 2011	0 - ₹10 Cr (As on Mar 31, 2025)	28 (As on Aug 01, 2025)

Pandorum has raised a total funding of $52.1M over 13 rounds. Its first funding round was on 2012. Its latest funding round was a Series B round on Mar 20, 2026 for $*****. 1 investor participated in its latest round. Pandorum has 34 institutional investors and 56 angel investors.

Here is the list of recent funding rounds of Pandorum:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2026	7542223	Series B	1047200	6469277	7657920	1652168
Jan 16, 2026	1560071	Series B	4248591	8065524	1128347	We Founder Circle
Oct 24, 2025	6470468	Series B	6215761	2771690	PROTONS CORPORATE SERVICES	Ashish Kacholia & 12 more

Access funding benchmarks and valuations. Sign up today!

View details of Pandorum's funding rounds and investors

The founders of Pandorum are Tuhin Bhowmick and Arun Chandru. Tuhin Bhowmick is the CEO of Pandorum.

Here are the details of Pandorum's key team members:

Tuhin Bhowmick: Co-Founder & CEO & Director of Pandorum and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number
Arun Chandru: Co-Founder& CTO & Director of Pandorum and founder of 2 other companies, Pandorum Technologies and Pandorum Technologies. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number

Pandorum's Board of Directors

Pandorum's board has 5 active members. Tuhin Bhowmick and Arun Chandru are part of team and Sailesh Tulshan, Sudipta Gautam and Sonal Asthana are independent board members.

Here is the list of Pandorum's board of directors:

Name	Type	Representing	Status	Duration
Tuhin Bhowmick	Team	-	Current	15y 2m
Arun Chandru	Team	-	Current	15y 2m
Sailesh Tulshan	Independent board member	-	Current	7y 11m
ecyuzvd	Independent board member	-	Current	9y 2m
ajnoygn	Independent board member	-	Past	2y 1m
emymrzx	Independent board member	-	Past	9y 8m

View details of Pandorum's Founder profiles and Board Members

Pandorum's employee count trend

Pandorum has 28 employees as of Aug 25. The total employee count is 8.0% more than what it was in Aug 24. Here is Pandorum's employee count trend over the years:

Uncover Pandorum's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pandorum include InSphero, Ncardia and Avita Medical. Here is the list of Top 10 competitors of Pandorum, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	InSphero 2009, Schlieren (Switzerland), Series D	Developer of cell based assays for drug screening	$35M	Redalpine, Venturelab & 8 others	67/100
2nd	Pandorum 2011, Bengaluru (India), Series B	Developer of regenerative medicine and 3D tissues	$52.1M	Burman Family, 500 Global & 88 others	65/100
3rd	Ncardia 2011, The Hague (Netherlands), Series C	Company offering hiPSC based products and services for drug discovery and development	$77.4M	Vesalius Biocapital Partners, Epimede & 9 others	61/100
4th	Avita Medical 1992, Cambridge (United Kingdom), Public	Regenerative and Respiratory Medicine product company	-	Orbimed, BioScience Managers & 6 others	59/100
5th	Orthofix 1980, Lewisville (United States), Public	Developer of reconstructive and regenerative solutions for bone-related conditions	-	-	59/100
6th	Stellular Bio 2014, Watertown (United States), Series A	Developer of a platform for producing allogeneic, stem-cell-derived platelet-like cells	$37.5M	Vivo Capital, Qiming & 5 others	59/100
7th	TreeFrog Therapeutics 2018, Talence (France), Series B	Developer of stem cells and organoids using proprietary technology	$84.2M	XAnge, Leonard Green and Partners & 12 others	59/100
8th	Organogenesis 1985, Canton (United States), Public	Regenerative tissue innovations for advanced wound care and surgical solutions	$30M	Eastward Capital Partners, Spring St. Group ... & 2 others	59/100
9th	Newcells Biotech 2014, Newcastle Upon Tyne (United Kingdom), Series B	Developer of induced pluripotent stem cells derived organoid models for research application	$14.4M	Mercia, Northstar Ventures & 7 others	58/100
10th	Ensoma 2019, Boston (United States), Series B	Developer of in vivo hematopoietic stem cell engineering for genomic medicine	$205M	5AM Ventures, Arix Bioscience & 18 others	58/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Pandorum's competitors? Click here to see the top ones

Founders own 23.39%, Funds own 19.08%, Enterprises own 22.35% and Angels (largest shareholder) own 24.48%. The net worth of Pandorum's founders is INR 192Cr as of Mar 30, 2026.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	23.39%	192Cr	4536721	4763526	1103634	8464728
Arun Chandru	6660488	6848327	3606977	8942719	3244550	7172405
Tuhin Bhowmick	9625604	8468105	4122094	9111563	2021253	2752137
Fund	19.08%	157Cr	1980409	1452474	1916717	6138998
We Founder Circle	0	0	0	0	0	0
Enterprise	22.35%	184Cr	7445487	2387134	7729502	8155476
Angel	24.48%	201Cr	5161878	1171191	7088122	6762013
Other People	4.66%	38.3Cr	1649	6567	6305	1158
ESOP Pool	6.04%	49.6Cr	829688	323829	706700	427290
Total	100.00%	821Cr	4270543	8301019	8065777	9493067